IL6
| Official symbol: | IL6 |
| Full name: | interleukin 6 |
| Location: | |
| Also known as: | IFNB2, BSF2, HSF, HGF, IL-6 |
| Entrez ID: | 3569 |
| Ensembl ID: | ENSG00000136244 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | NA |
|
|
|
| |
|
|
|
| Functional class: | Not specified |
| JensenLab PubMed score: | 30968.85 (Percentile rank: 99.94%) |
| PubTator score: | 22090.00 (Percentile rank: 99.97%) |
| Target development/druggability level: | TclinThese targets have activities in DrugCentral (ie. approved drugs) with known mechanism of action. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
